Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model

Abstract Background The bactericidal activity of an antimicrobial drug is generally assessed by in vitro bacterial time-kill experiments which do not include any components of the immune system, even though the innate immunity, the primary host defence, is probably able to kill a large proportion of...

Full description

Bibliographic Details
Main Authors: Elodie Anne Lallemand, Claudine Zemirline, Pierre-Louis Toutain, Alain Bousquet-Melou, Aude A. Ferran, Séverine Boullier
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s12917-021-02746-8
id doaj-7e2bc957757248328addf4ee43574941
record_format Article
spelling doaj-7e2bc957757248328addf4ee435749412021-01-10T12:24:31ZengBMCBMC Veterinary Research1746-61482021-01-0117111010.1186/s12917-021-02746-8Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro modelElodie Anne Lallemand0Claudine Zemirline1Pierre-Louis Toutain2Alain Bousquet-Melou3Aude A. Ferran4Séverine Boullier5InTheRes, Université de Toulouse, INRAE, ENVTCeva Santé AnimaleInTheRes, Université de Toulouse, INRAE, ENVTInTheRes, Université de Toulouse, INRAE, ENVTInTheRes, Université de Toulouse, INRAE, ENVTInTheRes, Université de Toulouse, INRAE, ENVTAbstract Background The bactericidal activity of an antimicrobial drug is generally assessed by in vitro bacterial time-kill experiments which do not include any components of the immune system, even though the innate immunity, the primary host defence, is probably able to kill a large proportion of pathogenic bacteria in immunocompetent patients. We developed an in vitro tripartite model to investigate the joint action of C57Bl/6 murine bone-marrow-derived macrophages and cephalexin on the killing of Staphylococcus aureus. Results By assessing the bactericidal effects on four bacterial inoculum sizes, we showed that macrophages can cooperate with cephalexin on inoculum sizes lower than 106 CFU/mL and conversely, protect S. aureus from cephalexin killing activity at the highest inoculum size. Cell analysis by flow cytometry revealed that macrophages were rapidly overwhelmed when exposed to large inoculums. Increasing the initial inoculum size from 105 to 107 CFU/mL increased macrophage death and decreased their ability to kill bacteria from six hours after exposure to bacteria. The addition of cephalexin at 16-fold MIC to 105 and 106 CFU/mL inoculums allowed the macrophages to survive and to maintain their bactericidal activity as if they were exposed to a small bacterial inoculum. However, with the highest inoculum size of 107 CFU/mL, the final bacterial counts in the supernatant were higher with macrophages plus cephalexin than with cephalexin alone. Conclusions These results suggest that if the bacterial population at the infectious site is low, as potentially encountered in the early stage of infection or at the end of an antimicrobial treatment, the observed cooperation between macrophages and cephalexin could facilitate its control.https://doi.org/10.1186/s12917-021-02746-8Staphylococcus aureusCephalexinMacrophagesKilling curvesAntimicrobial
collection DOAJ
language English
format Article
sources DOAJ
author Elodie Anne Lallemand
Claudine Zemirline
Pierre-Louis Toutain
Alain Bousquet-Melou
Aude A. Ferran
Séverine Boullier
spellingShingle Elodie Anne Lallemand
Claudine Zemirline
Pierre-Louis Toutain
Alain Bousquet-Melou
Aude A. Ferran
Séverine Boullier
Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
BMC Veterinary Research
Staphylococcus aureus
Cephalexin
Macrophages
Killing curves
Antimicrobial
author_facet Elodie Anne Lallemand
Claudine Zemirline
Pierre-Louis Toutain
Alain Bousquet-Melou
Aude A. Ferran
Séverine Boullier
author_sort Elodie Anne Lallemand
title Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
title_short Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
title_full Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
title_fullStr Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
title_full_unstemmed Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
title_sort dynamic interactions between cephalexin and macrophages on different staphylococcus aureus inoculum sizes: a tripartite in vitro model
publisher BMC
series BMC Veterinary Research
issn 1746-6148
publishDate 2021-01-01
description Abstract Background The bactericidal activity of an antimicrobial drug is generally assessed by in vitro bacterial time-kill experiments which do not include any components of the immune system, even though the innate immunity, the primary host defence, is probably able to kill a large proportion of pathogenic bacteria in immunocompetent patients. We developed an in vitro tripartite model to investigate the joint action of C57Bl/6 murine bone-marrow-derived macrophages and cephalexin on the killing of Staphylococcus aureus. Results By assessing the bactericidal effects on four bacterial inoculum sizes, we showed that macrophages can cooperate with cephalexin on inoculum sizes lower than 106 CFU/mL and conversely, protect S. aureus from cephalexin killing activity at the highest inoculum size. Cell analysis by flow cytometry revealed that macrophages were rapidly overwhelmed when exposed to large inoculums. Increasing the initial inoculum size from 105 to 107 CFU/mL increased macrophage death and decreased their ability to kill bacteria from six hours after exposure to bacteria. The addition of cephalexin at 16-fold MIC to 105 and 106 CFU/mL inoculums allowed the macrophages to survive and to maintain their bactericidal activity as if they were exposed to a small bacterial inoculum. However, with the highest inoculum size of 107 CFU/mL, the final bacterial counts in the supernatant were higher with macrophages plus cephalexin than with cephalexin alone. Conclusions These results suggest that if the bacterial population at the infectious site is low, as potentially encountered in the early stage of infection or at the end of an antimicrobial treatment, the observed cooperation between macrophages and cephalexin could facilitate its control.
topic Staphylococcus aureus
Cephalexin
Macrophages
Killing curves
Antimicrobial
url https://doi.org/10.1186/s12917-021-02746-8
work_keys_str_mv AT elodieannelallemand dynamicinteractionsbetweencephalexinandmacrophagesondifferentstaphylococcusaureusinoculumsizesatripartiteinvitromodel
AT claudinezemirline dynamicinteractionsbetweencephalexinandmacrophagesondifferentstaphylococcusaureusinoculumsizesatripartiteinvitromodel
AT pierrelouistoutain dynamicinteractionsbetweencephalexinandmacrophagesondifferentstaphylococcusaureusinoculumsizesatripartiteinvitromodel
AT alainbousquetmelou dynamicinteractionsbetweencephalexinandmacrophagesondifferentstaphylococcusaureusinoculumsizesatripartiteinvitromodel
AT audeaferran dynamicinteractionsbetweencephalexinandmacrophagesondifferentstaphylococcusaureusinoculumsizesatripartiteinvitromodel
AT severineboullier dynamicinteractionsbetweencephalexinandmacrophagesondifferentstaphylococcusaureusinoculumsizesatripartiteinvitromodel
_version_ 1724343009543192576